Drug Delivery Aspects : Volume 4: Expectations and Realities of Multifunctional Drug Delivery Systems. This item is unavailable.Drug Delivery Aspects : Volume 4: Expectations and Realities of Multifunctional Drug Delivery Systems

Drug Delivery Aspects: Expectations and Realities of Multifunctional Drug Delivery Systems examines the fabrication, optimization, and scale-up of nano and micro carriers. Various aspects like conversion of micro-nano particles into solid dosage form, large scale industry manufacturing challenges of nanocarriers, regulatory considerations on drug device combinations are featured in this volume. Written by a diverse range of international researchers from industry and academia, the chapters examine specific aspects of characterization and manufacturing for pharmaceutical applications as well as regulatory and policy aspects. The Multifunctional Drug Delivery Systems books provide a platform to discuss opportunities and challenges in development of micro-nanomedicine and other drug delivery systems, review industrial manufacturing challenges, discuss current and future market trends, facilitate the insight sharing within various expertise area, and establish collaborations between academic scientists, industrial and clinical researchers.

This book connects formulation scientists, regulatory experts, engineers, clinical experts and regulatory stake holders. The wide scope of the book ensures it is a valuable reference resource for researchers in both academia and the pharmaceutical industry who want to learn more about the status of drug delivery systems.

• Encompasses engineering aspects of nanocarriers
• Considers preclinical, regulatory and ethical guidelines on drug delivery
• Contains in-depth investigation of specific aspects of drug delivery systems

Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University, India, and has been a postdoctoral researcher in the Department of Pharmaceutics, Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany. Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany. She has authored several research articles, book chapters, and presented her research in many national/international conferences. She has filed multiple patent applications in the area of drug delivery and targeting. Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects. For her research, she has received many prestigious national and international awards among them include recently received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs), nanoemulsions, cancer drug targeting and the role of excipients in delivery systems. (www.ranjitas.com)